Increasing resilience of medical supply chains during the COVID-19 pandemic
Why building future resilience requires a delicate balance between increased flexibility, efficiency and welfare advantages of GVCs.
Why building future resilience requires a delicate balance between increased flexibility, efficiency and welfare advantages of GVCs.
Why revisiting traditional frames of reference on firm-level capabilities is crucial to unlock benefits of digital transformation.
Innovation can provide swift remedies to the COVID-19 linked recession. Policy should contain incentives to innovate in the long-term.